Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Malignant Fibrohistiocytic Tumors

fluorodeoxyglucose f18 has been researched along with Malignant Fibrohistiocytic Tumors in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (11.11)	29.6817
2010's	8 (88.89)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Athanasian, EA; Healey, JH; Ulaner, GA	1
Liu, Y; Xu, B	1
Dong, A; Gong, J; Wang, Y; Zuo, C	1
Fiore, MR; Fossati, P; Iannalfi, A; Orecchia, R; Tuan, J; Vischioni, B; Vitolo, V	1
Chen, J; Liu, J; Zheng, W; Zhou, Z; Zuo, C	1
Cui, XJ; Fang, N; Wang, YL; Wu, ZJ; Zeng, L	1
Luo, QY; Qiu, ZL; Shen, CT; Song, HJ; Wei, WJ	1
Hwang, SS; Park, SY; Park, YH	1
Beppu, Y; Kawai, A; Kobayashi, E; Seki, K; Tateishi, U	1

Reviews

1 review(s) available for fluorodeoxyglucose f18 and Malignant Fibrohistiocytic Tumors

Article	Year
Radiation therapy for retroperitoneal sarcoma. La Radiologia medica, 2014, Volume: 119, Issue:10 Topics: Chemotherapy, Adjuvant; Dose-Response Relationship, Radiation; Evidence-Based Medicine; Fluorodeoxyglucose F18; Histiocytoma, Malignant Fibrous; Humans; Leiomyosarcoma; Liposarcoma; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Retroperitoneal Neoplasms; Risk Assessment; Risk Factors; Sarcoma; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome	2014

Article

Year

Radiation therapy for retroperitoneal sarcoma.

La Radiologia medica, 2014, Volume: 119, Issue:10

Topics: Chemotherapy, Adjuvant; Dose-Response Relationship, Radiation; Evidence-Based Medicine; Fluorodeoxyglucose F18; Histiocytoma, Malignant Fibrous; Humans; Leiomyosarcoma; Liposarcoma; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Retroperitoneal Neoplasms; Risk Assessment; Risk Factors; Sarcoma; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome

2014

Other Studies

8 other study(ies) available for fluorodeoxyglucose f18 and Malignant Fibrohistiocytic Tumors

Article	Year
Pathologically Benign Lymph Nodes Can Mimic Malignancy on Imaging in Patients With Angiomatoid Fibrous Histiocytoma. Clinical orthopaedics and related research, 2017, Volume: 475, Issue:9 Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Databases, Factual; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Histiocytoma, Malignant Fibrous; Humans; Image-Guided Biopsy; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sentinel Lymph Node Biopsy; Young Adult	2017
Primary Hepatic Malignant Fibrous Histiocytoma on PET/CT. Clinical nuclear medicine, 2018, Volume: 43, Issue:6 Topics: Adult; Fluorodeoxyglucose F18; Histiocytoma, Malignant Fibrous; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2018
MRI and FDG PET/CT findings of malignant fibrous histiocytoma of the prostate. Clinical nuclear medicine, 2014, Volume: 39, Issue:10 Topics: Adult; Fluorodeoxyglucose F18; Histiocytoma, Malignant Fibrous; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed	2014
FDG PET/CT findings of malignant fibrous histiocytoma of the stomach. Clinical nuclear medicine, 2015, Volume: 40, Issue:5 Topics: Fluorodeoxyglucose F18; Histiocytoma, Malignant Fibrous; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed; Young Adult	2015
Metastatic Malignant Fibrous Histiocytoma in the Stomach: Imaging With 18F-FDG PET/CT. Clinical nuclear medicine, 2016, Volume: 41, Issue:2 Topics: Aged; Fluorodeoxyglucose F18; Histiocytoma, Malignant Fibrous; Humans; Male; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed	2016
Metastatic Malignant Fibrous Histiocytoma Infiltrating Sigmoid Colon: A Case Diagnosed With the Help of 18F-FDG PET/CT. Clinical nuclear medicine, 2016, Volume: 41, Issue:4 Topics: Colon, Sigmoid; Female; Fluorodeoxyglucose F18; Histiocytoma, Malignant Fibrous; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed	2016
The CT and F-FDG PET/CT appearance of primary renal malignant fibrous histiocytoma. Journal of medical imaging and radiation oncology, 2010, Volume: 54, Issue:4 Topics: Adult; Fluorodeoxyglucose F18; Follow-Up Studies; Histiocytoma, Malignant Fibrous; Humans; Kidney; Kidney Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2010
Bilateral adrenal gland metastasis from malignant fibrous histiocytoma: value of [F-18]FDG PET-CT for diagnosis of occult metastases. Annals of nuclear medicine, 2006, Volume: 20, Issue:10 Topics: Adrenal Gland Neoplasms; Aged; Female; Fluorodeoxyglucose F18; Histiocytoma, Malignant Fibrous; Humans; Liver Neoplasms; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2006